Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-31

Clinical Trial Update: Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice

View source ↗

Summary

This completed clinical trial evaluated treatment options for urinary tract infections caused by ESBL-producing bacteria in a general practice setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oslo | Conditions: Urinary Tract Infections | Status: COMPLETED